VanEck Associates Portfolio holdings
AUM
$88.3B
This Quarter Return
-20.84%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$37.7B
AUM Growth
-$10.7B
(-22%)
Cap. Flow
-$64.5M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
24%
Holding
1,460
New
90
Increased
669
Reduced
570
Closed
86
Top Buys
| 1 |
Kinross Gold
KGC
|
$219M |
| 2 |
Charles Schwab
SCHW
|
$89.6M |
| 3 |
TransUnion
TRU
|
$89.1M |
| 4 |
Rockwell Automation
ROK
|
$86M |
| 5 |
Ecolab
ECL
|
$85.7M |
Top Sells
| 1 |
Schlumberger
SLB
|
$135M |
| 2 |
Cheniere Energy
LNG
|
$120M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
$117M |
| 4 |
Lockheed Martin
LMT
|
$115M |
| 5 |
Bristol-Myers Squibb
BMY
|
$103M |
Sector Composition
| 1 | Materials | 34.09% |
| 2 | Technology | 25.82% |
| 3 | Energy | 9.46% |
| 4 | Healthcare | 7.07% |
| 5 | Financials | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Kirby Corp
KEX
$4.95B
| $29M | 0.08% |
476,940
-29,340
| -6% | -$1.79M |
|
202
Novartis
NVS
$248B
| $29M | 0.08% |
343,204
+123,649
| +56% | +$10.5M |
|
203
Novo Nordisk
NVO
$252B
| $28.8M | 0.08% |
517,060
+175,086
| +51% | +$9.75M |
|
204
Public Storage
PSA
$51.2B
| $28.6M | 0.08% |
91,426
-5,833
| -6% | -$1.82M |
|
205
Cencora
COR
$57.2B
| $28.5M | 0.08% |
201,173
+38,704
| +24% | +$5.48M |
|
206
Sanofi
SNY
$122B
| $28.4M | 0.08% |
566,931
+219,580
| +63% | +$11M |
|
207
Moderna
MRNA
$9.36B
| $28M | 0.07% |
196,138
-102,523
| -34% | -$14.6M |
|
208
Takeda Pharmaceutical
TAK
$47.8B
| $27.9M | 0.07% |
1,989,772
+862,502
| +77% | +$12.1M |
|
209
Toro Company
TTC
$7.95B
| $27.1M | 0.07% |
357,500
+90,489
| +34% | +$6.86M |
|
210
Main Street Capital
MAIN
$5.87B
| $27M | 0.07% |
699,836
-79,056
| -10% | -$3.05M |
|
211
GSK
GSK
$79.3B
| $26.6M | 0.07% |
488,346
+175,474
| +56% | +$9.55M |
|
212
VanEck Merk Gold Trust
OUNZ
$1.91B
| $26.5M | 0.07% |
1,513,767
+1,018,769
| +206% | +$17.9M |
|
|
NEE.PRQ
213
DELISTED
NextEra Energy, Inc. 6.219% Corporate Units
NEE.PRQ
| $26.2M | 0.07% |
533,590
+79,726
| +18% | +$3.92M |
|
|
CTLT
214
DELISTED
CATALENT, INC.
CTLT
| $26.1M | 0.07% |
243,445
+80,141
| +49% | +$8.6M |
|
215
Bilibili
BILI
$9.2B
| $25.7M | 0.07% |
1,004,791
-110,520
| -10% | -$2.83M |
|
216
Accenture
ACN
$158B
| $25.4M | 0.07% |
91,358
-1,093
| -1% | -$303K |
|
|
SGEN
217
DELISTED
Seagen Inc. Common Stock
SGEN
| $25.2M | 0.07% |
142,494
+9,533
| +7% | +$1.69M |
|
218
Golub Capital BDC
GBDC
$3.91B
| $25M | 0.07% |
1,931,033
-179,873
| -9% | -$2.33M |
|
219
Blackstone Secured Lending
BXSL
$6.75B
| $25M | 0.07% |
+1,057,237
| New | +$25M |
|
220
Helix Energy Solutions
HLX
$952M
| $24.4M | 0.06% |
7,877,907
+472,058
| +6% | +$1.46M |
|
|
SOLN
221
DELISTED
The Southern Company
SOLN
| $24.4M | 0.06% |
460,223
+68,765
| +18% | +$3.64M |
|
222
Teva Pharmaceuticals
TEVA
$21.5B
| $24.2M | 0.06% |
3,213,734
+1,324,951
| +70% | +$9.96M |
|
223
Viatris
VTRS
$12.3B
| $24.1M | 0.06% |
2,297,172
+719,175
| +46% | +$7.53M |
|
224
Hercules Capital
HTGC
$3.51B
| $24M | 0.06% |
1,780,910
-91,012
| -5% | -$1.23M |
|
225
Prospect Capital
PSEC
$1.34B
| $24M | 0.06% |
3,431,123
-502,834
| -13% | -$3.51M |
|